NSCLC-SCLC transformation can be monitored in plasma samples by detection of increases of TP53 mutations and, more specifically, of copy number changes of SCLC-associated markers MYCL1, SOX2, and SOX4[22]. This evidence concerns the gene SOX4 and small cell lung carcinoma.